
Driven by passion, talent and agility, TransEnterix is a rapidly growing medical–device company that seeks to advance the field of minimally invasive surgery through innovation.
TransEnterix’s revolutionary SPIDER™ Surgical System has been cleared by the U.S. Food and Drug Administration for use in patients. The SPIDER™ Surgical System enhances traditional laparoscopic surgery by providing greater flexibility and enhanced capabilities.
TransEnterix relies on rapid prototyping, intense pre–clinical labs and hands–on collaboration to accelerate learning and bring new medical devices to market more quickly.
1/29/10 11:57 AM
TransEnterix looks to enter into new class of surgery (Surgical Products Magazine)
1/25/10 3:49 PM
David Gill Named Chief Financial Officer at TransEnterix
1/19/10 11:32 AM
TransEnterix ready to move forward (The News & Observer)
12/11/09 9:02 AM
TransEnterix Awarded the "SE Deal of the Year: Venture Capital Transaction" Award by Southeast BIO.
11/17/09 10:35 AM
TransEnterix Named ‘Most Innovative Technology Company’
in the State by North Carolina Technology Association
11/10/09 10:09 AM
TransEnterix names John Tushar Vice President of Business Development